These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37886145)

  • 1. Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management.
    Hakeem IJ
    Bioinformation; 2023; 19(5):565-570. PubMed ID: 37886145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
    Pandey S; Singh BK
    Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
    Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
    Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
    Koly HK; Sutradhar K; Rahman MS
    J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: Molecular docking, ADME profiling and molecular dynamics simulations.
    Azmal M; Hossen MS; Shohan MNH; Taqui R; Malik A; Ghosh A
    PLoS One; 2024; 19(6):e0304490. PubMed ID: 38833492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational identification of potential acetylcholinesterase (AChE) and monoamine oxidase-B inhibitors from
    Sofela SO; Ibrahim A; Ogbodo UC; Bodun DS; Nwankwo DO; Mafimisebi M; Abdulrasheed B; Balogun T; Opeyemi I
    In Silico Pharmacol; 2024; 12(1):49. PubMed ID: 38828442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease.
    Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D
    Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment.
    Farihi A; Bouhrim M; Chigr F; Elbouzidi A; Bencheikh N; Zrouri H; Nasr FA; Parvez MK; Alahdab A; Ahami AOT
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893530
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploring the therapeutic potential of prolinamides as multi-targeted agents for Alzheimer's disease treatment: molecular docking and molecular dynamic simulation studies.
    Olalekan SO; Obakachi VA; Badeji AA; Akinsipo Oyelaja OB; Familoni O; Asekun OT; Oladipo SD; Osinubi AD
    In Silico Pharmacol; 2024; 12(2):80. PubMed ID: 39224128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
    Son M; Park C; Rampogu S; Zeb A; Lee KW
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase.
    Rehman S; Ali Ashfaq U; Sufyan M; Shahid I; Ijaz B; Hussain M
    PLoS One; 2022; 17(3):e0264074. PubMed ID: 35239683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitargeted Molecular Docking and Dynamic Simulation Studies of Bioactive Compounds from
    Mirza FJ; Zahid S; Amber S; Sumera ; Jabeen H; Asim N; Ali Shah SA
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of phyto-ligand molecules from the honey bee products for Alzheimer's disease as novel inhibitors of BACE-1: small molecule bioinformatics strategies as amyloid-based therapy.
    Nisa N; Rasmita B; Arati C; Uditraj C; Siddhartha R; Dinata R; Bhanushree B; Bidanchi RM; Manikandan B; Laskar SA; Abinash G; Pori B; Roy VK; Gurusubramanian G
    Environ Sci Pollut Res Int; 2023 Apr; 30(17):51143-51169. PubMed ID: 36808033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
    Singh M; Jindal D; Kumar R; Pancham P; Haider S; Gupta V; Mani S; R R; Tiwari RK; Chanda S
    J Alzheimers Dis; 2023; 93(2):705-726. PubMed ID: 37066913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.
    Saha B; Das A; Jangid K; Kumar A; Kumar V; Jaitak V
    Curr Res Struct Biol; 2024; 7():100124. PubMed ID: 38292820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.